Thirty Madison Vaults to Unicorn Status, Raises $140 Million

Thirty Madison, a health-care startup that specializes in treating chronic conditions, has raised $140 million in funding, valuing the company at more than $1 billion and granting it so-called unicorn status.

In 2020, Thirty Madison’s revenue tripled, and in the first quarter of 2021, sales surpassed an annual run-rate of $100 million, Gutentag said. Thirty Madison’s personalized treatment and chronic condition-management tools, including medication and ongoing communication with a physician, are used by by more than 250,000 active customers.

Founded in 2017 by Steven Gutentag and Demetri Karagas, Thirty Madison operates four verticals: Keeps, Cove, Evens and Picnic, which specialize in men’s hair loss, migraines, gastrointestinal conditions and allergies, respectively.

Read More